These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 32017049)

  • 21. Short-Course Radiotherapy Followed by Neoadjuvant Bevacizumab, Capecitabine, and Oxaliplatin and Subsequent Radical Treatment in Primary Stage IV Rectal Cancer: Long-Term Results of a Phase II Study.
    Bisschop C; van Dijk TH; Beukema JC; Jansen RLH; Gelderblom H; de Jong KP; Rutten HJT; van de Velde CJH; Wiggers T; Havenga K; Hospers GAP
    Ann Surg Oncol; 2017 Sep; 24(9):2632-2638. PubMed ID: 28560600
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adjuvant vs. neoadjuvant radiochemotherapy for locally advanced rectal cancer: the German trial CAO/ARO/AIO-94.
    Sauer R; Fietkau R; Wittekind C; Rödel C; Martus P; Hohenberger W; Tschmelitsch J; Sabitzer H; Karstens JH; Becker H; Hess C; Raab R;
    Colorectal Dis; 2003 Sep; 5(5):406-15. PubMed ID: 12925071
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of preoperative radiation therapy for resectable rectal adenocarcinoma when combined with oral tegafur-uracil modulated with leucovorin: results from a phase II study.
    Uzcudun AE; Batlle JF; Velasco JC; Sánchez Santos ME; Carpeño Jde C; Grande AG; Juberías AM; Piñeiro EH; Olivar LM; García AG
    Dis Colon Rectum; 2002 Oct; 45(10):1349-58. PubMed ID: 12394434
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Neoadjuvant radiochemotherapy in the treatment of locally advanced rectal tumors].
    Rápolti E; Szigeti A; Farkas R; Bellyei S; Boronkai A; Papp A; Gömöri E; Horváth OP; Mangel L
    Magy Onkol; 2009 Dec; 53(4):345-9. PubMed ID: 20071306
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poor-risk rectal cancer.
    Chau I; Brown G; Cunningham D; Tait D; Wotherspoon A; Norman AR; Tebbutt N; Hill M; Ross PJ; Massey A; Oates J
    J Clin Oncol; 2006 Feb; 24(4):668-74. PubMed ID: 16446339
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monthly tegafur-uracil maintenance for increasing relapse-free survival in ypStage III rectal cancer patients after preoperative radiotherapy, radical resection, and 12 postoperative chemotherapy cycles: a retrospective study.
    Kuo YH; Lai CH; Huang CY; Chen CJ; Huang YC; Huang WS; Chin CC
    BMC Cancer; 2019 Aug; 19(1):815. PubMed ID: 31419963
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neoadjuvant sandwich treatment with oxaliplatin and capecitabine administered prior to, concurrently with, and following radiation therapy in locally advanced rectal cancer: a prospective phase 2 trial.
    Gao YH; Lin JZ; An X; Luo JL; Cai MY; Cai PQ; Kong LH; Liu GC; Tang JH; Chen G; Pan ZZ; Ding PR
    Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1153-60. PubMed ID: 25442042
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic factors and patterns of failure after surgery for T4 rectal cancer in the beyond total mesorectal excision era.
    Peacock O; Waters PS; Bressel M; Lynch AC; Wakeman C; Eglinton T; Koh CE; Lee PJ; Austin KK; Warrier SK; Solomon MJ; Frizelle FA; Heriot AG
    Br J Surg; 2019 Nov; 106(12):1685-1696. PubMed ID: 31339561
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Practical neoadjuvant and adjuvant therapies for rectal cancer. How many patients are actually recruited in multimodality therapy concepts? An analysis of the Tumour Centre Schwerin].
    Sauer J; Sobolewski K; Dommisch K
    Zentralbl Chir; 2009 Sep; 134(5):450-4. PubMed ID: 19757345
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phase II Trial of Preoperative Radiation With Concurrent Capecitabine, Oxaliplatin, and Bevacizumab Followed by Surgery and Postoperative 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX), and Bevacizumab in Patients With Locally Advanced Rectal Cancer: 5-Year Clinical Outcomes ECOG-ACRIN Cancer Research Group E3204.
    Landry JC; Feng Y; Prabhu RS; Cohen SJ; Staley CA; Whittington R; Sigurdson ER; Nimeiri H; Verma U; Benson AB
    Oncologist; 2015 Jun; 20(6):615-6. PubMed ID: 25926352
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radical resection of rectal cancer primary tumor provides effective local therapy in patients with stage IV disease.
    Nash GM; Saltz LB; Kemeny NE; Minsky B; Sharma S; Schwartz GK; Ilson DH; O'Reilly E; Kelsen DP; Nathanson DR; Weiser M; Guillem JG; Wong WD; Cohen AM; Paty PB
    Ann Surg Oncol; 2002 Dec; 9(10):954-60. PubMed ID: 12464586
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nomograms to predict survival and the risk for developing local or distant recurrence in patients with rectal cancer treated with optional short-term radiotherapy.
    van Gijn W; van Stiphout RGPM; van de Velde CJH; Valentini V; Lammering G; Gambacorta MA; Påhlman L; Bujko K; Lambin P
    Ann Oncol; 2015 May; 26(5):928-935. PubMed ID: 25609247
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Retrospective Analysis on Two-week Short-course Pre-operative Radiotherapy in Elderly Patients with Resectable Locally Advanced Rectal Cancer.
    Shi C; Zhou H; Li X; Cai Y
    Sci Rep; 2016 Nov; 6():37866. PubMed ID: 27886277
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adjuvant chemotherapy using CPT-11, leucovorin plus bolus 5-fluorouracil and radiotherapy in patients with rectal cancer. A feasibility study.
    Kalofonos HP; Kardamakis D; Bamias A; Skarlos D; Papakostas P; Bafaloukos D; Sakantamis A; Pavlidis N; Fountzilas G
    Anticancer Res; 2003; 23(2C):1687-91. PubMed ID: 12820441
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer.
    Bujko K; Nowacki MP; Nasierowska-Guttmejer A; Michalski W; Bebenek M; Kryj M
    Br J Surg; 2006 Oct; 93(10):1215-23. PubMed ID: 16983741
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intraoperative radiotherapy as an immediate adjuvant treatment of rectal cancer due to limited access to external-beam radiotherapy.
    Potemin S; Kübler J; Uvarov I; Wenz F; Giordano F
    Radiat Oncol; 2020 Jan; 15(1):11. PubMed ID: 31924250
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preoperative chemoradiation and coloanal J pouch reconstruction for low rectal cancer.
    Chaudhry V; Nittala M; Prasad ML
    Am Surg; 2000 Apr; 66(4):387-93. PubMed ID: 10776877
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Feasibility of Neoadjuvant FOLFOX Therapy Without Radiotherapy for Baseline Resectable Rectal Cancer.
    Koizumi M; Yamada T; Shinji S; Yokoyama Y; Takahashi G; Iwai T; Takeda K; Hara K; Ohta K; Uchida E; Yoshida H
    In Vivo; 2018; 32(4):937-943. PubMed ID: 29936483
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictors of disease-free survival in rectal cancer patients undergoing curative proctectomy.
    Stewart D; Yan Y; Mutch M; Kodner I; Hunt S; Lowney J; Birnbaum E; Read T; Fleshman J; Dietz D
    Colorectal Dis; 2008 Nov; 10(9):879-86. PubMed ID: 19037929
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Local tumor control and (disease-free) survival after surgery with pre- and intraoperative radiotherapy for primary non-resectable rectal carcinoma and local recurrence].
    Mannaerts GH; Martijn H; Rutten HJ; Hanssens PE; Wiggers T
    Ned Tijdschr Geneeskd; 2001 Jul; 145(30):1460-6. PubMed ID: 11503316
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.